Chunyu Hua

Dalian, 116044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

CROT overactivation within peroxisomes confers chemoresistance to non-small cell lung cancer by targeting fatty acid oxidation-Nrf2-ferroptosis resistance axis.

CROT overactivation within peroxisomes confers chemoresistance to non-small cell lung cancer by targeting fatty acid oxidation-Nrf2-ferroptosis resistance axis.

Journal: Pharmacological research

Published: May 07, 2025

Corrigendum to "TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression" [Free Radic. Biol. Med. 177 (2021) 31-47].

Corrigendum to "TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression" [Free Radic. Biol. Med. 177 (2021) 31-47].

Journal: Free radical biology & medicine

Published: December 07, 2024

KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300.

KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300.

Journal: International journal of biological sciences

Published: May 20, 2024

Lumbrokinase Extracted from Earthworms Synergizes with Bevacizumab and Chemotherapeutics in Treating Non-Small Cell Lung Cancer by Targeted Inactivation of BPTF/VEGF and NF-κB/COX-2 Signaling.

Lumbrokinase Extracted from Earthworms Synergizes with Bevacizumab and Chemotherapeutics in Treating Non-Small Cell Lung Cancer by Targeted Inactivation of BPTF/VEGF and NF-κB/COX-2 Signaling.

Journal: Biomolecules

Published: April 29, 2024

A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance.

A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance.

Journal: PLoS biology

Published: September 23, 2022

Targeting regulation of VEGF by BPTF in non-small cell lung cancer and its potential clinical significance.

Targeting regulation of VEGF by BPTF in non-small cell lung cancer and its potential clinical significance.

Journal: European journal of medical research

Published: September 08, 2022

MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4.

MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4.

Journal: Cancer science

Published: August 30, 2022

BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A.

BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A.

Journal: Redox biology

Published: June 09, 2022

TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression.

TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression.

Journal: Free radical biology & medicine

Published: August 27, 2021

SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression.

SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression.

Journal: Molecular oncology

Published: March 02, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026